{"text_format":"3","workbook":"xls","n_sheets":3,"sheets":["Sheet1","Sheet2","Sheet3"],"not_rendered":{"external_links":1,"defined_names":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":37,"n_cols":5,"rows_kept":37,"flags":["formulas_cached_only"]}
["附件1  2012年广东省药学会肝炎用药研究基金经费安排表"]
["项目编号","项目名称","申请者","所在单位","实际安排金额（元）"]
["2012G37","恩替卡韦治疗慢乙肝病毒学应答与HBV准种变迁的关系研究","彭劼","南方医科大学南方医院",30000]
["2012G23","恩替卡韦最佳停药时机、停药反跳率及预防策略的研究","徐启桓","中山大学附属第三医院",30000]
["2012G38","IL-21对HBV特异性CTL的调控及其与慢性乙肝抗病毒治疗疗效的关系","邓洪","中山大学附属第三医院",20000]
["2012G01","几种核苷类抗乙肝病毒药物治疗方案的药物经济学评价和数学模型的建立","叶晓光","广州医学院第二附属医院",20000]
["2012G02","恩替卡韦对核苷（酸）初治的失代偿期乙肝肝硬化患者的疗效研究","徐沛演","广州市花都区人民医院",20000]
["2012G20","联合或单用恩替卡韦治疗对聚乙二醇干扰素应答不佳的HBeAg阳性慢性乙型肝炎病例的临床对照观察","廖金瑶","广东省人民医院",15000]
["2012G18","恩替卡韦、拉米夫定-阿德夫韦酯初始联合对照治疗失代偿期乙肝肝硬化患者的临床研究","张春兰","广州市第八人民医院",10000]
["2012G34","比较恩替卡韦联合阿德福韦酯及拉米夫定联合阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎患者的长期疗效及安全性","孙剑","南方医科大学南方医院",10000]
["2012G24","L类核苷类似物治疗导致HBV rtA181T/sW172*变异的研究","吴诗品","深圳市人民医院",10000]
["2012G21","恩替卡韦治疗核苷经治患者的长期队列研究","童光东","深圳市中医院",10000]
["2012G07","恩替卡韦单药与拉米夫定联合阿德福韦酯治疗乙型肝炎肝硬化疗效比较","林占洲","惠州市中心人民医院",10000]
["2012G04","恩替卡韦与拉米夫定治疗失代偿期乙肝肝硬化的疗效对比","陈其奎","中山大学孙逸仙纪念医院",10000]
["2012G06","抗乙型肝炎病毒治疗对肝癌术后复发的预防作用研究","刘超","中山大学孙逸仙纪念医院",10000]
["2012G27","四种慢性乙肝治疗方案疗效及成本-效果分析","谢莉霞","深圳市南山区人民医院",10000]
["2012G12","抗病毒治疗对慢性乙型肝炎后肝硬化门脉高压的影响","沙卫红","广东省人民医院",10000]
["2012G33","不同厂家恩替卡韦口服制剂的质量研究和评价","刘杰","中山大学附属第三医院",10000]
["2012G10","肝瞬时弹性（Fibroscan）值评价核苷类药物抗病毒治疗对慢乙肝患者肝纤维化的影响","张倩华","中山市第二人民医院",10000]
["2012G17","恩替卡韦和拉米夫定联合阿德福韦酯治疗HBeAg阳性慢性乙型肝炎的临床研究","李耀才","茂名市人民医院",10000]
["2012G26","恩替卡韦治疗ALT正常或轻度升高慢性乙型肝炎的临床研究","敖飞健","深圳市第三人民医院",10000]
["2012G25","核苷（酸）类似物治疗慢性乙型肝炎的PCT研究","舒丹","深圳市第三人民医院",10000]
["2012G03","中药降脂提高CHB合并肝脂肪变抗病毒治疗应答的临床研究","袁冬生","广州中医药大学第一附属医院",5000]
["2012G05","一项前瞻性随机对照研究：拉米夫定和恩替卡韦预防鼻咽癌化疗相关性HBV再激活的疗效对比","刘宜敏","中山大学孙逸仙纪念医院",5000]
["2012G22","核苷类似物治疗慢乙肝患者e抗原血清学转换与应答不佳的免疫学特征随访","杨桂林","深圳市第三人民医院",5000]
["2012G08","恩替卡韦联合胸腺肽α1治疗乙型肝炎肝硬化的疗效观察","甄月映","广东省江门市中心医院",5000]
["2012G16","聚乙二醇干扰素α-2b和核苷(酸)类药物联合治疗E抗原阳性慢性乙肝的初步研究","周小辉","汕头大学医学院第一附属医院",5000]
["2012G19","慢性乙型病毒性肝炎合并肺结核患者抗病毒治疗疗效分析","施海燕","广州市第八人民医院",5000]
["2012G13","恩替卡韦对慢性乙型重症肝炎病人的先天免疫的影响","刘卫东","汕头大学医学院第二附属医院",5000]
["2012G35","比较恩替卡韦和替比夫定对慢性乙肝患者生存质量的影响","郑萍","南方医科大学附属南方医院",5000]
["2012G14","恩替卡韦联合胸腺肽α1治疗HBeAg阳性的慢性乙型肝炎临床研究","姚展成","汕头大学医学院第二附属医院",5000]
["2012G15","恩替卡韦治疗慢性乙型肝炎疗效预测因素研究","吴春晓","珠海市人民医院",5000]
["2012G36","阿德福韦酯应答不佳的慢性乙型肝炎后续治疗探讨","赵登蕴","东莞市东华医院",5000]
["2012G11","恩替卡韦治疗失代偿期乙型肝炎肝硬化的疗效观察","肖湘明","汕头市中心医院中山大学附属汕头医院",5000]
["2012G28","肝动脉栓塞化疗联合恩替卡韦对肝癌合并乙肝病毒感染患者预后相关性分析","潘莹","中山大学肿瘤防治中心",5000]
["2012G30","恩替卡韦对慢性乙型肝炎患者IL-12及HBeAg的影响","李茹冰","广州军区广州总医院",5000]
["2012G09","恩替卡韦联合云芝胞内糖肽治疗慢性乙型肝炎疗效观察","黄坚彤","广东省江门市新会区人民医院",5000]

{"sheet":"Sheet2","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}

{"sheet":"Sheet3","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}